Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Anne-Sophie Hamy
Based on 23 articles published since 2009
(Why 23 articles?)
||||
Expertise Level
The expertise of Anne-Sophie Hamy ranks in the
  • Top 0.9%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 23 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Hamy, A-S   ·   Hamy, Anne-Sophie   ·   Hamy, A S   ·   Hamy, Anne-sophie
Work Locations
Details
Most likely:    INSERM France      
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
2011
  • Radiologie, Hôpital Saint-Louis - Inserm U728 - Université Paris VII, 1 Avenue Claude Vellefaux, Paris, 75010, France. · Pubmed 21854572
Probable:    Institut Curie      
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Department of Biostatistics, Institut Curie, Paris, France. · Pharmacogenomics Unit, Department of Genetics, Institut Curie, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Biology Department, Institut Gustave Roussy, Villejuif, France. · APHP Pathology Department, Hôpital Saint Louis, Paris Diderot University, Paris, France. · Pathology Department, Hôpital René-Huguenin, Institut Curie, Saint-Cloud, France. · Pathology Department, Institut Gustave Roussy, Villejuif, France. · Pathology Department, Institut Curie, Paris, France. · APHP, Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Pubmed 27592112
  • Department of Surgery, Institut Curie, 75005, Paris, France. · Breast Unit, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, Northern Ireland. · Department of Medical Oncology, 75005, Institut Curie, Paris, France. · Paris Descartes University, 75006, Paris, France. · Department of Tumor Biology, Institut Curie, 75005, Paris, France. · Department of Radiotherapy, Institut Curie, 75005, Paris, France. · Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, 75005, Paris, France. · UMR932 Immunity and Cancer, INSERM, Institut Curie, 75005, Paris, France. · Pubmed 27494111
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
2014
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
Probable:    Sorbonne University      
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 23 total) written by Anne-Sophie Hamy about Breast Neoplasms:

  • (no title) 2018
  • Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy. 2018
  • Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. 2018
  • Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status. 2017
  • Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer. 2017
  • A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways. 2016
  • BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy. 2016
  • Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery. 2016
  • Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies. 2016
  • Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort. 2016
Show List of Full Article Records
Google Searches

Learn more about Anne-Sophie Hamy using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
INSERM France
Institut Curie
Sorbonne University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
INSERM France
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
2011
  • Radiologie, Hôpital Saint-Louis - Inserm U728 - Université Paris VII, 1 Avenue Claude Vellefaux, Paris, 75010, France. · Pubmed 21854572
Institut Curie
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Department of Biostatistics, Institut Curie, Paris, France. · Pharmacogenomics Unit, Department of Genetics, Institut Curie, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Biology Department, Institut Gustave Roussy, Villejuif, France. · APHP Pathology Department, Hôpital Saint Louis, Paris Diderot University, Paris, France. · Pathology Department, Hôpital René-Huguenin, Institut Curie, Saint-Cloud, France. · Pathology Department, Institut Gustave Roussy, Villejuif, France. · Pathology Department, Institut Curie, Paris, France. · APHP, Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Pubmed 27592112
  • Department of Surgery, Institut Curie, 75005, Paris, France. · Breast Unit, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, Northern Ireland. · Department of Medical Oncology, 75005, Institut Curie, Paris, France. · Paris Descartes University, 75006, Paris, France. · Department of Tumor Biology, Institut Curie, 75005, Paris, France. · Department of Radiotherapy, Institut Curie, 75005, Paris, France. · Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, 75005, Paris, France. · UMR932 Immunity and Cancer, INSERM, Institut Curie, 75005, Paris, France. · Pubmed 27494111
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
2014
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
Sorbonne University
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
Hopitaux Universitaires Saint-Louis Lariboisiere Fernand-Widal
2016
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie, 75004 Paris, France; Inserm 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Pubmed 26803206
2014
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie clinique, 75004 Paris, France; Inserm, 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie Cellulaire, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Service de Biochimie, Laboratoire des Urgences et Gardes, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie de la Reproduction, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Université Paris VI, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France. · Pubmed 25246112
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Biostatistic Department, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Molecular Biology Department, Paris 75475, France [2] INSERM/CNRS/University Paris Diderot UMR 944/7212, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Pathology Department, Paris 75475, France [2] University Paris Diderot, UMR-S-728 INSERM, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Radiology Department, Paris 75475, France. · Pubmed 24569467
2012
  • Breast Disease Center, Saint Louis Hospital, AP-HP, Université Paris VII, 1 avenue Claude Vellefaux, 75010 Paris, France. · Pubmed 21769528
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France, · Pubmed 25432784
2012
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 22241914
  • Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23243198
2011
  • Department of Nuclear Medicine, Saint-Louis Hospital, Assistance publique Hôpitaux de Paris, Paris, France. · Pubmed 21057787
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 21880576
  • Radiologie, Hôpital Saint-Louis - Inserm U728 - Université Paris VII, 1 Avenue Claude Vellefaux, Paris, 75010, France. · Pubmed 21854572
  • Service d'anatomie pathologique, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, AP-HP, 75010 Paris, France; Université Paris 7, 75013 Paris, France. · Pubmed 21601117
Universite Paris 7 Diderot
2016
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie, 75004 Paris, France; Inserm 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Pubmed 26803206
2014
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie clinique, 75004 Paris, France; Inserm, 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie Cellulaire, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Service de Biochimie, Laboratoire des Urgences et Gardes, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie de la Reproduction, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Université Paris VI, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France. · Pubmed 25246112
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Biostatistic Department, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Molecular Biology Department, Paris 75475, France [2] INSERM/CNRS/University Paris Diderot UMR 944/7212, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Pathology Department, Paris 75475, France [2] University Paris Diderot, UMR-S-728 INSERM, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Radiology Department, Paris 75475, France. · Pubmed 24569467
2012
  • Breast Disease Center, Saint Louis Hospital, AP-HP, Université Paris VII, 1 avenue Claude Vellefaux, 75010 Paris, France. · Pubmed 21769528
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France, · Pubmed 25432784
2012
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 22241914
  • Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23243198
2011
  • Department of Nuclear Medicine, Saint-Louis Hospital, Assistance publique Hôpitaux de Paris, Paris, France. · Pubmed 21057787
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 21880576
  • Radiologie, Hôpital Saint-Louis - Inserm U728 - Université Paris VII, 1 Avenue Claude Vellefaux, Paris, 75010, France. · Pubmed 21854572
  • Service d'anatomie pathologique, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, AP-HP, 75010 Paris, France; Université Paris 7, 75013 Paris, France. · Pubmed 21601117
Yearly article counts 03251413400
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.